这份由腾讯研究院发布的《塑造自己的下一个版本 2026 前沿科技趋势》报告，以生命力、体力、脑力、创造力、追求五大维度为核心，眺望 2030 年前沿 科技对人类自身与社会的重塑，提出科技进步应以人为本，核心是通过技术助力人类塑造更好的 "下一个版本"，同时直面技术发展带来的机遇与挑战， 明确个人、企业和社会的应对方向。以下是核心内容总结： 生命力 2030：从 "活得更久" 到 "活得更好"，开启生命第三次转型 转型背景：人类预期寿命增长速度大幅放缓，单纯延长寿命的 "果实" 已被耗尽，全球转向追求健康寿命（无严重慢性病、维持良好生活质量的年限）， 这一转型对全球经济影响深远，延长 1 年健康寿命将产生 38 万亿美元全球经济价值。 核心技术 基因疗法：进入 "生命代码优化" 时代，CRISPR 技术 2.0、体内递送系统完善推动预防性基因疗法实现临床突破（如一次性治疗高血脂、高血压），RNA 疗法实现慢性病长效控制和重症治疗，表观遗传重编程更开启逆转衰老的曙光，2026 年初将有相关人体临床试验启动。 人工智能：成为医疗的 "操作系统"，生成式 AI 大幅压缩药物研发周期，AI 与多组学结合实现 75 种癌 ...

Core Insights - Shanghai Rongtai Health Technology Co., Ltd. announced a strategic cooperation with Shanghai Aoshah Intelligent Technology Co., Ltd. to explore the integration of health technology and exoskeleton technology, marking a significant step in their collaboration [1][2] - Aoshah Intelligent, a leader in the consumer-grade exoskeleton field in China, aims to accelerate the penetration of exoskeleton technology into the consumer health market through this partnership [2] Company Overview - Rongtai Health has been deeply involved in the health industry for 28 years, with products sold in over 80 countries and regions, and has sold more than 3 million massage chairs [2] - Aoshah Intelligent offers a diverse product line that includes upper limb, waist, lower limb, and full-body exoskeletons, indicating a strong position in the consumer-grade market [2] Strategic Collaboration - The partnership will leverage Rongtai Health's manufacturing and market channel advantages alongside Aoshah Intelligent's technological expertise, focusing on after-sales service, production, and other collaborative dimensions [1] - Future plans include establishing deep cooperation in three core areas: technological health, industry applications, and technology research and development, aiming for complementary advantages and collaborative growth [1]

Core Insights - Rongtai Health has entered a strategic partnership with Shanghai Aoshark Intelligent Technology, marking a significant step in integrating health technology with exoskeleton technology [1][2] - The collaboration aims to explore the potential of "human-machine symbiosis" and promote the popularization of exoskeleton technology in public health scenarios [1] - Rongtai Health has invested 20.6 million yuan in Aoshark Intelligent, indicating a commitment to deepening their partnership [1] Company Overview - Rongtai Health has been in the health industry for 28 years and has sold over 3 million massage chairs globally, reaching more than 80 countries and regions [1] - The company is focused on building a "big health ecosystem" through strategic collaborations [1] Aoshark Intelligent Overview - Aoshark Intelligent is a leading company in the consumer-grade exoskeleton field in China, known for its advanced technology and performance in major events like the Hangzhou Asian Games [1] - The company offers a diverse product line that includes upper limb, waist, lower limb, and full-body exoskeletons [1] Future Collaboration Plans - Rongtai Health plans to leverage its manufacturing and market channel advantages to collaborate with Aoshark Intelligent in after-sales service, production, and other areas [2] - The partnership will focus on three core areas: technological health, industry applications, and technological research and development [2]